Landmark Bank’s AbbVie ABBV Stock Holding History

Landmark Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$455K	Sell	5,134 -29	-0.6%	-$2.41K	0.1%	51
2019 Q3	$391K	Buy	5,163 +90	+2%	+$6.17K	0.25%	54
2019 Q2	$369K	Buy	5,073 +324	+7%	+$25.5K	0.24%	59
2019 Q1	$383K	Buy	4,749 +1,887	+66%	+$154K	0.26%	57
2018 Q4	$264K	Buy	2,862 +56	+2%	+$4.92K	0.2%	79
2018 Q3	$265K	Hold	2,806	–	–	0.16%	83
2018 Q2	$260K	Buy	+2,806	New	+$274K	0.17%	83

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Landmark Bank's ABBV Position: Q4 2019 in Review

Landmark Bank reduced its AbbVie (ABBV) stake by 0.56% in Q4 2019, selling an estimated $2.41K and leaving 5,134 shares worth $455K. The position accounts for 0.1% of the portfolio, ranked #51.

Landmark Bank first reported a position in ABBV in Q2 2018 and has held it in 7 quarters since. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

Landmark Bank held 5,134 shares of AbbVie worth $455K as of Q4 2019.
Landmark Bank sold 29 AbbVie shares in Q4 2019, an estimated $2.41K.
AbbVie made up 0.1% of Landmark Bank's portfolio in Q4 2019, its #51 holding.
Landmark Bank first reported a position in AbbVie in Q2 2018 and has held it in 7 quarters since.
2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Landmark Bank's 13F filing for Q4 2019, filed 12 Feb 2020.